Maloney Ezekiel, Menashe Sarah J, Iyer Ramesh S, Ringold Sarah, Chakraborty Amit K, Ishak Gisele E
Department of Radiology, University of Washington, Seattle,, WA, USA.
Department of Radiology, Seattle Children's Hospital, 4800 Sand Point Way NE, R-5417, Seattle, WA, 98105-3071, USA.
Pediatr Radiol. 2018 Oct;48(11):1642-1654. doi: 10.1007/s00247-018-4177-x. Epub 2018 Jul 3.
Localized craniofacial scleroderma is a rare pediatric disease that involves a spectrum of discoloration, fibrosis and hemiatrophy of the face and scalp. Children with localized craniofacial scleroderma may have neurological symptoms, and in this context often undergo diagnostic imaging of the brain.
To catalogue neuroimaging abnormalities in patients with localized craniofacial scleroderma treated at our institution, review their clinical courses and compare this data with prior studies.
Following Institutional Review Board approval, an imaging database search identified 10 patients with localized craniofacial scleroderma and neuroimaging abnormalities treated at our institution. Neuroimaging exams and the electronic medical record were reviewed for each case.
The most common indications for neuroimaging were headache or seizure (80% of cases). The most common neuroimaging abnormalities were T2-hyperintense, subcortical white matter lesions ipsilateral to the cutaneous lesion (90% of cases) on magnetic resonance imaging (MRI). Calcifications or blood products (50%), cysts (40%) and abnormal enhancement (20%) were also observed. A positron emission tomography (PET) scan obtained for a single case demonstrated diminished F-fluorodeoxyglucose (FDG) avidity corresponding to the dominant focus of signal abnormality on MRI. Progressive neuroimaging abnormalities were present in 30% of cases. There was no consistent relationship between changes in neurological symptoms following treatment and neuroimaging findings.
Our results are similar to previously published data. In the absence of new or worsening neurological symptoms, the role of neuroimaging for follow-up of localized craniofacial scleroderma is unclear. Knowledge of intracranial neuroimaging abnormalities that are commonly associated with localized craniofacial scleroderma helps to distinguish these lesions from others that have similar appearance.
局限性颅面部硬皮病是一种罕见的儿科疾病,表现为面部和头皮出现一系列变色、纤维化和半侧萎缩。局限性颅面部硬皮病患儿可能出现神经症状,在此情况下常需进行脑部诊断性影像学检查。
对在我们机构接受治疗的局限性颅面部硬皮病患者的神经影像学异常进行分类,回顾其临床病程,并将这些数据与先前的研究进行比较。
经机构审查委员会批准后,通过影像学数据库搜索,确定了10例在我们机构接受治疗且存在神经影像学异常的局限性颅面部硬皮病患者。对每个病例的神经影像学检查和电子病历进行了回顾。
神经影像学检查最常见的指征是头痛或癫痫发作(80%的病例)。最常见的神经影像学异常是磁共振成像(MRI)显示皮肤病变同侧的T2高信号、皮质下白质病变(90%的病例)。还观察到钙化或血液制品(50%)、囊肿(40%)和异常强化(20%)。对1例患者进行的正电子发射断层扫描(PET)显示,与MRI上主要信号异常灶相对应的氟脱氧葡萄糖(FDG)摄取减少。30%的病例存在进行性神经影像学异常。治疗后神经症状的变化与神经影像学结果之间没有一致的关系。
我们的结果与先前发表的数据相似。在没有新的或恶化的神经症状的情况下,神经影像学检查在局限性颅面部硬皮病随访中的作用尚不清楚。了解与局限性颅面部硬皮病常见相关的颅内神经影像学异常有助于将这些病变与其他外观相似的病变区分开来。